Net delta exposure for Acadia Pharmaceuticals Inc (ACAD) options was $12.98M per 1% move at the Nov 4, 2026 close. It has been positive on 6 of the last 20 trading days. That is its highest reading in 4 weeks.
Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.
Delta Exposure by Strike
Showing results for ACAD, 2026-11-20(m), calls & puts
Delta Exposure Stats
Showing results for ACAD, 2026-11-20(m), calls & puts
Net Delta Exposure by Expiration
Showing results for ACAD, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net DEX | Call DEX | Put DEX | Call Wall | Put Wall |
|---|
ACAD Delta Exposure FAQ
What is delta exposure (DEX)?
Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.
Is ACAD delta exposure positive or negative?
Acadia Pharmaceuticals net delta exposure was positive on Nov 4, 2026, at $12.98M. It has been positive on 6 of the last 20 trading days.
How has ACAD delta exposure changed recently?
Acadia Pharmaceuticals net delta exposure went from -$12.68M on Oct 7, 2026 to $12.98M on Nov 4, 2026. See the ACAD delta exposure history for a longer view.
What is Acadia Pharmaceuticals Inc?
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise into making a difference for underserved neurological and rare disease communities around the world.